Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Study of Divalproex Extended Release Monotherapy in Ambulatory Bipolar Spectrum Disorder With Moderate-to-Severe Hypomania or Mild Mania

This study has been completed.
Sponsor:
Collaborators:
Abbott
University of Cincinnati
Information provided by:
Lindner Center of HOPE
ClinicalTrials.gov Identifier:
NCT00278772
First received: January 13, 2006
Last updated: May 24, 2010
Last verified: May 2010